In MM, TGF-β is secreted in the bone marrow microenvironment by both MM cells and bone marrow stromal cells, resulting in the increased secretion of VEGF and IL6 by stromal cells, thereby leading to the proliferation of malignant cells [46]. This evidence concerns the gene TGFB1 and Miyoshi myopathy.